Location: Faculty of Health and Social Care, H3
This is a free event.
Dementia is a truly global health issue, affecting 44million people worldwide.
There are 850,000 people living with dementia in the UK today. By 2025 the number is expected to rise to over one million and by
2050 it is projected to exceed 2 million.
(Alzheimer's Research UK).
The term dementia describes a set of symptoms including memory loss, mood changes, and problems with communication and reasoning. This public lecture with guest speaker Dr Simon Ridley include a presentation around key challenges and progress in dementia research from both a scientific and research perspective, including areas such as epidemiology and risk reduction, dementia pathologies, new drug targets, trials and treatments, and biomarkers.
Viewed by some as having fewer opportunities in academia, this discussion will explore how dementia research capacity and initiatives, alongside the funding landscape (UK and global) can be supported.
The event is supported by the Postgraduate Medical Institute a cross-faculty institution with shared interest and expertise in medical and clinical research and postgraduate training, collaboration and research. (PGMI logo to be included).
Simon joined Alzheimer's Research UK in January 2009. As Director of Research he is responsible for the delivery of funding programmes and partnerships. Simon follows new developments in dementia research and is a regular media spokesperson on research matters. Simon has extensive experience as a researcher and has also worked in industry. Prior to taking up post at Alzheimer’s Research UK, Simon a Research Fellow at University of Cambridge, where he also completed his PhD